Analyst Ratings for Harpoon Therapeutics (HARP)
HARP Rating Summary
HARP Price Target Summary
- Highest: $15.00 (Cantor Fitzgerald)
- Lowest: $7.00 (Wedbush)
- Average: $11.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.14 (+435.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$11.14 (+435.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2022 | Wedbush | Robert Driscoll | Upgrade | Outperform (Neutral) |
7.00 (5.00) |
2.00 (2.08) |
4% | Details |
| 5/13/2022 | Cantor Fitzgerald | Jennifer Kim | New Coverage | Overweight (N/A) |
15.00 (33.00) |
1.86 (2.08) |
11.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
